Metraipolis › archive › dc_fb53ea2a6d9c

Reduced versus standard dose apixaban for secondary prevention of cancer-associated venous thromboembolism: A systematic review and meta-analysis — Europe PMC PMID:41487575

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41487575
DOI
10.3389/fonc.2025.1690984
License (as archived)
solo-consultazione
Archived
2026-11-07T12:42:45.554Z
SHA-256 of the archived text
ea628f3c2526e775172cd2b82ef321d65ae10dd14b11ae2a31a0a8c4b8d5e791
Stable URL of this page
https://metraipolis.com/documento/dc_fb53ea2a6d9c

How to cite

Reduced versus standard dose apixaban for secondary prevention of cancer-associated venous thromboembolism: A systematic review and meta-analysis — Europe PMC PMID:41487575 — Europe PMC (en), https://europepmc.org/article/MED/41487575 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fb53ea2a6d9c (Metraipolis archive dc_fb53ea2a6d9c, sha256 ea628f3c2526e775172cd2b82ef321d65ae10dd14b11ae2a31a0a8c4b8d5e791)
BibTeX
@misc{dcfb53ea2a6d9c,
  title = {Reduced versus standard dose apixaban for secondary prevention of cancer-associated venous thromboembolism: A systematic review and meta-analysis — Europe PMC PMID:41487575},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41487575},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fb53ea2a6d9c; sha256 ea628f3c2526e775172cd2b82ef321d65ae10dd14b11ae2a31a0a8c4b8d5e791},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41487575. Agents can read the archived copy with the MCP tool read_document.